Stuart A. Arbuckle
2019
In 2019, Stuart A. Arbuckle earned a total compensation of $6.9M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,260,000 |
|---|---|
| Option Awards | $1,575,011 |
| Salary | $770,962 |
| Stock Awards | $3,215,952 |
| Other | $37,608 |
| Total | $6,859,533 |
Arbuckle received $3.2M in stock awards, accounting for 47% of the total pay in 2019.
Arbuckle also received $1.3M in non-equity incentive plan, $1.6M in option awards, $771K in salary and $37.6K in other compensation.
Rankings
In 2019, Stuart A. Arbuckle's compensation ranked 1,410th out of 13,971 executives tracked by ExecPay. In other words, Arbuckle earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,410 out of 13,971 | 90th |
Division Manufacturing | 495 out of 5,701 | 91st |
Major group Chemicals And Allied Products | 149 out of 2,200 | 93rd |
Industry group Drugs | 119 out of 1,886 | 94th |
Industry Pharmaceutical Preparations | 90 out of 1,398 | 94th |
Source: SEC filing on April 28, 2020.
Arbuckle's colleagues
We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2019.
2019
Jeffrey Leiden
Vertex Pharmaceuticals
Chairman
2019
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
2019
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
2019
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
2019
Paul Silva
Vertex Pharmaceuticals
SVP & Corporate Controller
2019
Ian Smith
Vertex Pharmaceuticals